LegoChem Biosciences Inc
KOSDAQ:141080
Balance Sheet
Balance Sheet Decomposition
LegoChem Biosciences Inc
LegoChem Biosciences Inc
Balance Sheet
LegoChem Biosciences Inc
| Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||
| Cash & Cash Equivalents |
1 146
|
1 367
|
614
|
1 296
|
1 767
|
1 343
|
1 622
|
2 443
|
2 968
|
8 623
|
2 202
|
22 204
|
44 238
|
29 442
|
21 391
|
15 529
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
78
|
382
|
2 826
|
8 623
|
1 682
|
15 954
|
5 381
|
50
|
0
|
0
|
|
| Cash Equivalents |
1 146
|
1 367
|
614
|
1 296
|
1 767
|
1 343
|
1 544
|
2 061
|
142
|
0
|
520
|
6 250
|
38 857
|
29 393
|
21 391
|
15 529
|
|
| Short-Term Investments |
2 500
|
6 590
|
3 800
|
4 643
|
3 717
|
18 705
|
28 409
|
16 655
|
27 036
|
12 603
|
59 500
|
20 000
|
7 000
|
141 498
|
137 574
|
77 574
|
|
| Total Receivables |
149
|
73
|
158
|
80
|
134
|
806
|
410
|
9 577
|
13 173
|
15 960
|
26 347
|
57 181
|
32 139
|
46 529
|
19 817
|
20 880
|
|
| Accounts Receivables |
80
|
42
|
45
|
45
|
61
|
784
|
262
|
9 258
|
12 700
|
15 620
|
17 800
|
11 336
|
20 687
|
22 594
|
13 331
|
15 665
|
|
| Other Receivables |
69
|
31
|
113
|
35
|
73
|
22
|
148
|
319
|
473
|
340
|
8 547
|
45 845
|
11 452
|
23 934
|
6 486
|
5 215
|
|
| Inventory |
27
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
439
|
936
|
755
|
2 021
|
285
|
271
|
199
|
197
|
|
| Other Current Assets |
64
|
122
|
162
|
274
|
878
|
233
|
177
|
944
|
6 006
|
7 087
|
4 575
|
10 012
|
16 349
|
11 211
|
12 638
|
20 439
|
|
| Total Current Assets |
3 886
|
8 150
|
4 735
|
6 293
|
6 496
|
21 086
|
30 618
|
29 620
|
49 622
|
45 209
|
93 379
|
111 419
|
100 011
|
228 951
|
191 619
|
134 619
|
|
| PP&E Net |
256
|
225
|
188
|
185
|
201
|
1 200
|
1 159
|
3 491
|
6 866
|
7 846
|
10 275
|
12 144
|
7 618
|
24 432
|
26 492
|
25 424
|
|
| PP&E Gross |
256
|
225
|
188
|
185
|
201
|
1 200
|
1 159
|
3 491
|
6 866
|
7 846
|
10 275
|
12 144
|
7 618
|
24 432
|
26 492
|
25 424
|
|
| Accumulated Depreciation |
168
|
263
|
350
|
483
|
604
|
868
|
1 248
|
4 818
|
4 566
|
5 739
|
6 870
|
9 180
|
5 787
|
5 102
|
7 510
|
9 722
|
|
| Intangible Assets |
277
|
453
|
9
|
14
|
44
|
58
|
123
|
13 731
|
12 437
|
11 356
|
10 110
|
8 988
|
8 150
|
8 601
|
7 889
|
6 901
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
19 134
|
14 331
|
11 465
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
90
|
0
|
22
|
0
|
0
|
0
|
0
|
0
|
100
|
100
|
100
|
0
|
0
|
0
|
96
|
98
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
996
|
990
|
3 903
|
3 916
|
5 185
|
7 326
|
16 517
|
22 631
|
19 825
|
17 340
|
|
| Other Long-Term Assets |
22
|
9
|
35
|
122
|
183
|
810
|
860
|
1 473
|
2 292
|
2 346
|
2 638
|
1 600
|
3 618
|
8 619
|
6 610
|
5 119
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
19 134
|
14 331
|
11 465
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
4 531
N/A
|
8 836
+95%
|
4 989
-44%
|
6 614
+33%
|
6 924
+5%
|
23 154
+234%
|
33 755
+46%
|
68 440
+103%
|
89 551
+31%
|
82 238
-8%
|
121 686
+48%
|
141 477
+16%
|
135 912
-4%
|
293 233
+116%
|
252 530
-14%
|
189 502
-25%
|
|
| Liabilities | |||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6 060
|
7 570
|
9 117
|
8 178
|
7 692
|
6 555
|
6 846
|
7 285
|
7 095
|
|
| Accrued Liabilities |
5
|
5
|
42
|
51
|
50
|
68
|
95
|
126
|
181
|
165
|
136
|
364
|
222
|
418
|
3 879
|
11 376
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1 800
|
0
|
0
|
0
|
0
|
0
|
0
|
2 700
|
11 847
|
|
| Current Portion of Long-Term Debt |
0
|
2 573
|
20
|
20
|
20
|
0
|
0
|
0
|
6 174
|
6 704
|
0
|
111
|
78
|
2 858
|
9 333
|
269
|
|
| Other Current Liabilities |
377
|
593
|
459
|
651
|
1 757
|
1 826
|
832
|
1 200
|
1 076
|
1 655
|
1 632
|
7 257
|
7 154
|
6 897
|
5 407
|
6 485
|
|
| Total Current Liabilities |
383
|
3 171
|
521
|
721
|
1 827
|
1 894
|
927
|
9 186
|
15 001
|
17 640
|
9 946
|
15 424
|
14 009
|
17 018
|
28 603
|
37 072
|
|
| Long-Term Debt |
2 469
|
85
|
4 061
|
45
|
25
|
1 051
|
9 069
|
9 829
|
7 853
|
8 519
|
0
|
2 074
|
3 909
|
9 410
|
216
|
528
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
1 025
|
3 935
|
3 922
|
3 357
|
2 414
|
2 881
|
1 253
|
3 928
|
1 129
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1 259
|
3 630
|
2 160
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
434
|
798
|
1 875
|
1 713
|
1 718
|
2 125
|
2 691
|
2 312
|
2 714
|
3 257
|
4 032
|
5 189
|
4 615
|
4 103
|
2 983
|
3 681
|
|
| Total Liabilities |
3 286
N/A
|
4 054
+23%
|
6 457
+59%
|
2 480
-62%
|
3 570
+44%
|
5 070
+42%
|
13 712
+170%
|
25 262
+84%
|
29 490
+17%
|
34 032
+15%
|
20 021
-41%
|
27 728
+38%
|
23 786
-14%
|
34 459
+45%
|
32 932
-4%
|
41 281
+25%
|
|
| Equity | |||||||||||||||||
| Common Stock |
1 155
|
1 436
|
1 291
|
1 786
|
2 762
|
3 567
|
3 828
|
4 522
|
4 971
|
4 977
|
5 999
|
6 004
|
12 053
|
13 624
|
13 834
|
14 211
|
|
| Retained Earnings |
3 054
|
3 479
|
7 472
|
10 665
|
13 449
|
19 560
|
28 434
|
36 671
|
51 441
|
64 289
|
90 294
|
78 812
|
86 138
|
109 586
|
105 383
|
30 740
|
|
| Additional Paid In Capital |
3 145
|
6 825
|
4 712
|
13 013
|
14 041
|
34 077
|
44 649
|
75 327
|
106 530
|
107 518
|
185 492
|
186 652
|
183 136
|
349 792
|
93 881
|
97 523
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3 075
|
2 446
|
1 789
|
2 273
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4 879
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
468
|
95
|
0
|
2 500
|
4 712
|
8 353
|
|
| Total Equity |
1 246
N/A
|
4 782
+284%
|
1 468
N/A
|
4 134
N/A
|
3 354
-19%
|
18 084
+439%
|
20 044
+11%
|
43 178
+115%
|
60 060
+39%
|
48 206
-20%
|
101 665
+111%
|
113 749
+12%
|
112 126
-1%
|
258 775
+131%
|
219 599
-15%
|
148 221
-33%
|
|
| Total Liabilities & Equity |
4 531
N/A
|
8 836
+95%
|
4 989
-44%
|
6 614
+33%
|
6 924
+5%
|
23 154
+234%
|
33 755
+46%
|
68 440
+103%
|
89 551
+31%
|
82 238
-8%
|
121 686
+48%
|
141 477
+16%
|
135 912
-4%
|
293 233
+116%
|
252 530
-14%
|
189 502
-25%
|
|
| Shares Outstanding | |||||||||||||||||
| Common Shares Outstanding |
7
|
7
|
8
|
8
|
9
|
14
|
15
|
18
|
20
|
20
|
21
|
21
|
24
|
24
|
26
|
28
|
|
| Preferred Shares Outstanding |
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
3
|
2
|
0
|
|